Literature DB >> 14729860

ApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36.

Maria C de Beer1, Lawrence W Castellani, Lei Cai, Arnold J Stromberg, Frederick C de Beer, Deneys R van der Westhuyzen.   

Abstract

The class B scavenger receptors SR-BI and CD36 exhibit a broad ligand binding specificity. SR-BI is well characterized as a HDL receptor that mediates selective cholesteryl ester uptake from HDL. CD36, a receptor for oxidized LDL, also binds HDL and mediates selective cholesteryl ester uptake, although much less efficiently than SR-BI. Apolipoprotein A-II (apoA-II), the second most abundant HDL protein, is considered to be proatherogenic, but the underlying mechanisms are unclear. We previously showed that apoA-II modulates SR-BI-dependent binding and selective uptake of cholesteryl ester from reconstituted HDL. To investigate the effect of apoA-II in naturally occurring HDL on these processes, we compared HDL without apoA-II (from apoA-II null mice) with HDLs containing differing amounts of apoA-II (from C57BL/6 mice and transgenic mice expressing a mouse apoA-II transgene). The level of apoA-II in HDL was inversely correlated with HDL binding and selective cholesteryl ester uptake by both scavenger receptors, particularly CD36. Interestingly, for HDL lacking apoA-II, the efficiency with which CD36 mediated selective uptake reached a level similar to that of SR-BI. These results demonstrate that apoA-II exerts a marked effect on HDL binding and selective lipid uptake by the class B scavenger receptors and establishes a potentially important relationship between apoA-II and CD36.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729860     DOI: 10.1194/jlr.M300417-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.

Authors:  Thomas A Hughes; Frankie Stentz; Thomas Gettys; Steven R Smith
Journal:  Metabolism       Date:  2006-01       Impact factor: 8.694

2.  Graded effects of proteinuria on HDL structure in nephrotic rats.

Authors:  Gregory C Shearer; John W Newman; Bruce D Hammock; George A Kaysen
Journal:  J Am Soc Nephrol       Date:  2005-03-23       Impact factor: 10.121

3.  Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  Biochemistry       Date:  2012-06-01       Impact factor: 3.162

4.  High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli.

Authors:  Loren E Smith; Jun Yang; Leah Goodman; Xinqi Huang; Rong Huang; James Dressman; Jamie Morris; R A Gangani D Silva; W Sean Davidson; Giorgio Cavigiolio
Journal:  J Lipid Res       Date:  2012-05-25       Impact factor: 5.922

5.  Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.

Authors:  Monica Gomaraschi; Alice Ossoli; Samuela Castelnuovo; Sara Simonelli; Chiara Pavanello; Gloria Balzarotti; Marcello Arca; Alessia Di Costanzo; Tiziana Sampietro; Gaetano Vaudo; Damiano Baldassarre; Fabrizio Veglia; Guido Franceschini; Laura Calabresi
Journal:  J Lipid Res       Date:  2017-03-28       Impact factor: 5.922

6.  Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.

Authors:  Yao Wang; Manabu Niimi; Kazutoshi Nishijima; Ahmed Bilal Waqar; Ying Yu; Tomonari Koike; Shuji Kitajima; Enqi Liu; Tomohiro Inoue; Masayuki Kohashi; Yuka Keyamura; Tomohiro Yoshikawa; Jifeng Zhang; Loretta Ma; Xiaohui Zha; Teruo Watanabe; Yujiro Asada; Y Eugene Chen; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

7.  Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity.

Authors:  Eric T Alexander; Michael C Phillips
Journal:  J Lipid Res       Date:  2013-10-01       Impact factor: 5.922

8.  Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism.

Authors:  R Han; R Lai; Q Ding; Z Wang; X Luo; Y Zhang; G Cui; J He; W Liu; Y Chen
Journal:  Diabetologia       Date:  2007-07-18       Impact factor: 10.122

9.  HDL-apoA-II Is Strongly Associated with 1-Year Mortality in Acute Heart Failure Patients.

Authors:  Iva Klobučar; Vesna Degoricija; Ines Potočnjak; Matias Trbušić; Gudrun Pregartner; Andrea Berghold; Eva Fritz-Petrin; Hansjörg Habisch; Tobias Madl; Saša Frank
Journal:  Biomedicines       Date:  2022-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.